Erythropoietin levels in the different clinical forms of hereditary spherocytosis

British Journal of Haematology

Volumn 131, Issue 4, 2005, Pages 534-542

  Rocha, S ^b   Costa, E ^c   Catarino, C ^b,d   Belo, L ^b,d   Castro, E M B ^b,d   Barbot, J ^c   Quintanilha, A ^b,d   Santos Silva, A ^a,b,d  

^a Departamento de Ciências Biológicas   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c HOSPITAL MARIA PIA   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Erythropoietin; Erythropoietin response; Hereditary spherocytosis; Outcome of hereditary spherocytosis

Indexed keywords

BILIRUBIN; ERYTHROPOIETIN; MEMBRANE PROTEIN; PLASMA PROTEIN;

ADULT; ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ERYTHROPOIESIS; HEMOGLOBIN DETERMINATION; HEREDITARY SPHEROCYTOSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RETICULOCYTE COUNT; SPLENECTOMY; AGED; BLOOD; ERYTHROCYTE MEMBRANE; HOSPITALIZATION; METABOLISM;

ADULT; AGED; BILIRUBIN; BLOOD PROTEINS; CHILD; ERYTHROCYTE MEMBRANE; ERYTHROPOIESIS; ERYTHROPOIETIN; HUMANS; MEMBRANE PROTEINS; RETICULOCYTE COUNT; SEVERITY OF ILLNESS INDEX; SPHEROCYTOSIS, HEREDITARY; SPLENECTOMY;

EID: 33644810908     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05802.x     Document Type: Article

References (45)

1. Agre P. Asimos A. Casella J.F. McMillan C. ( 1986) Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. New England Journal of Medicine, 315, 1579 1583.
2. Alloisio N. Maillet P. Carré G. ( 1996) Hereditary spherocytosis with band 3 deficiency. Association with a non-sense mutation of the band 3 gene (Allele Lyon), and aggravation by a low expression allele occurring in trans (Allele Genas). Blood, 88, 1062 1069.
3. Alloisio N. Texier P. Valliet A. ( 1997) Modulation of clinical expression and band 3 deficiency in hereditary spherocytosis. Blood, 90, 414 420.
4. Baird R.N. Macpherson A.I.S. Richmond J. ( 1971) Red-blood cell survival after splenectomy in congenital spherocytosis. Lancet, ii, 1060 1061.
5. Bolton-Maggs P.H.B. Stevens R.F. Dodd N.J. Lamont G. Tittensor P. King M.-J. ( 2004) Guidelines for the diagnosis and management of Hereditary Spherocytosis. British Journal of Haematology, 126, 455 474.
6. Bradford M.M. ( 1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of the protein dye binding. Analytical Biochemistry, 72, 248 254.
7. Cazzola M. Guarnone R. Cerani P. Centenara E. Rovati A. Beguin Y. ( 1998) Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood, 91, 2139 2145.
8. Chapman R.G. McDonald L.L. ( 1968) Red cell life span after splenectomy in hereditary spherocytosis. Journal of Clinical Investigation, 47, 2263 2267.
9. D'Andrea A.D. Zon L.I. ( 1990) Erythropoietin receptor. Subunit structure and activation. Journal of Clinical Investigation, 86, 681 687.
10. Dodge J.T. Mitchell C. Hanahan D.J. ( 1963) The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Archives of Biochemistry and Biophysics, 100, 119 130.
11. Eber S.W. Armbrust R. Schröter W. ( 1990) Variable clinical severity of hereditary spherocytosis: relation to erythrocyte spectrin concentration, osmotic fragility and autohemolysis. Journal of Pediatrics, 117, 409 416.
12. Ebert B.L. Bunn H.F. ( 1999) Regulation of the erythropoietin gene. Blood, 94, 1864 1877.
13. Erslev A.J. ( 2001) Anemia of chronic disease. In: Williams Hematology, 6th edn ( ed. by E. Beutler M.A. Lichtman B.S. Coller T.J. Kipps U. Seligsohn pp. 481 487. McGraw-Hill, New York.
14. Fairbanks G. Steck T.L. Wallach D.F.H. ( 1971) Electrophoresis of the major polypeptides of the human erythocyte membrane. Biochemistry, 10, 2606 2616.
15. Faquin W.C. Schneider T.J. Goldberg M.A. ( 1992) Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood, 79, 1987 1994.
16. Fisher J.W. ( 2003) Erythropoietin: physiology and pharmacology update. Experimental Biology and Medicine, 228, 1 14.
17. Guarnone R. Centenara E. Zappa M. Zanella A. Barosi G. ( 1996) Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis. British Journal of Haematology, 92, 150 154.
18. Hillman R.S. Ault K.A. ( 2002) Clinical approach to anemia. In: Hematology in Clinical Practice, 3rd edn ( ed. by R.S. Hillman K.A. Ault pp. 12 26. McGraw-Hill, New York, NY.
19. International Committee for Standardization in Haematology ( 1984) ICSH reference method for staining of blood and bone marrow films by azure B and eosin Y (Romanowsky stain). British Journal of Haematology, 57, 707 710.
20. Iolascon A. del Giudice E.M. Perrotta S. Alloisio N. Morlé L. Delaunay J. ( 1998) Hereditary Spherocytosis: from clinical to molecular defects. Haematologica, 83, 240 257.
21. Jelkmann W. ( 1992) Erythropoietin: structure, control of production, and function. Physiological Reviews, 72, 449 489.
22. Kay M.M.B. Goodman S.R. Sorensen K. Whitfield C.F. Wong P. Zaki L. Rudloff V. ( 1983) Senescent cell antigen is immunologically related to band 3. Proceedings of the National Academy of Sciences United States of America, 80, 1631 1635.
23. Kay M.M.B. Marchalonis J.J. Schluter S.F. Bosman G. ( 1991) Human erythrocyte aging: cellular and molecular biology. Transfusion Medical Review, 3, 173 195.
24. Krantz S.B. ( 1991) Erythropoietin. Blood, 77, 419 434.
25. Lacombe C. Mayeux P. ( 1998) Biology of erythropoietin. Haematologica, 83, 724 732.
26. Laemmli U.K. ( 1970) Cleavage of structural proteins during the assembly of the head of the bacteriophage T. Nature, 227, 680 685.
27. Lanciotti M. Perutelli P. Valetto A. Di Martino D. Mori P.G. ( 1997) Ankyrin deficiency is the most common defect in dominant and non dominant hereditary spherocytosis. Haematologica, 82, 460 462.
28. Lappin T. ( 2003) The cellular biology of erythropoietin receptors. The Oncologist, 8, 15 18.
29. Lutz A. ( 1992) Naturally occurring anti-band 3 antibodies. Transfusion Medical Review, 6, 201 211.
30. Lutz H.U. Bussolino F. Flepp R. Fasler S. Stammler P. Kazatchkin M.D. Arese P. ( 1987) Naturally occurring anti-band 3 antibodies and complement together mediate together mediate phagocytosis of oxidatively stressed human erythrocytes. Proceedings of the National Academy of Sciences USA, 84, 7368 7372.
31. Macdougall I.C. ( 2004) Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients Archives de Pediatrie, 19, V73 V78.
32. Maiese K. Li F. Chong Z.Z. ( 2005) New avenues of exploration for of erythropoietin. Journal of the American Medical Association, 293, 90 95.
33. Means R.T., Jr. Krantz S.B. ( 1992) Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 80, 1639 1647.
34. Miraglia del Giudice E. Iolascon A. Pinto L. Nobili B. Perrotta S. ( 1994) Erythrocyte membrane protein alterations underlying clinical heteregoneity in hereditary spherocytosis. British Journal of Haematology, 93, 828 834.
35. Miraglia del Giudice E. Francese M. Nobili B. Morlé L. Cutillo S. Delaunay J. Perrotta S. ( 1998) High frequency of de novo mutations in ankyrin gene (ANK1) in children with hereditary spherocytosis. Journal of Pediatrics, 132, 117 120.
36. Regan F. Newlands M. Bain B.J. ( 2001) Acquired haemolytic anaemias. In: Dacie and Lewis Practical Haematology ( ed. by S.M. Lewis B.J. Bain I. Bates pp. 199 229. Churchill Livingstone, London.
37. Reliene R. Mariani M. Zanella A. Reinhart W.H. Ribeiro M.L. Miraglia del Giudice E. Perrotta S. Iolascon A. Eber S. Lutz H.U. ( 2002) Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient herediatry spherocytosis. Blood, 100, 2208 2215.
38. Remy I. Wilson I.A. Michnick S.W. ( 1999) Erythropoietin receptor activation by ligand-induced conformation change. Science, 283, 990 993.
39. Rocha S. Rebelo I. Costa E. Catarino C. Belo L. Castro E.M.B. Cabeda J.M. Barbot J. Quintanilha A. Santos-Silva A. ( 2005) Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. European Journal of Haematology, 74, 374 380.
40. Roper D. Layton M. Mitchell Lewis S. ( 2001) Investigation of the hereditary hemolytic anemias: membrane and enzyme abnormalities. In: Dacie and Lewis Practical Haematology ( ed. by S.M. Lewis B.J. Bain I. Bates pp. 167 198. Churchill Livingstone, London.
41. Schiff M. Hays S. Sann L. Putet G. ( 2003) Recombinant human erythropoietin (r-HuEPO) therapy in a newborn with hereditary spherocytosis. Archives de Pediatrie, 10, 333 336.
42. Taniguchi S. Dai C.H. Price J.O. Krantz S.B. ( 1997) Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells. Blood, 90, 2244 2252.
43. Tchernia G. Delhommeau F. Perrotta S. Cynober T. Bader-Meunier B. Nobili B. Rohrlich P. Salomon J.L. Sagot-Benevot S. Miraglia del Giudice E. Delaunay J. DeMattia D. Schischmanoff P.O. Mohandas N. Iolascon A. ( 2000) Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis. The Hematology Journal, 1, 146 152.
44. Tse W.T. Lux S.E. ( 1999) Red blood cell membrane disorders. British Journal of Haematology, 104, 2 13.
45. Zinkham W.H. ( 1969) Indications for and complications of splenectomy in childhood. Medical Times, 97, 106 110.